Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults

Critical Care

Volumn 14, Issue 5, 2010, Pages

  Adamzik, Michael ^a   Eggmann, Martin ^a   Frey, Ulrich H ^a   Görlinger, Klaus ^a   Bröcker Preuß, Martina ^b   Marggraf, Günter ^a   Saner, Fuat ^a   Eggebrecht, Holger ^a   Peters, Jürgen ^a   Hartmann, Matthias ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; THROMBOELASTOMETRY; BIOSYNTHESIS; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; CRITICAL ILLNESS; HEMOLYSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; STANDARD; THROMBOELASTOGRAPHY; UPREGULATION;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HEMOLYSIS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SEPSIS; THROMBELASTOGRAPHY; UP-REGULATION;

EID: 77957329384     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9284     Document Type: Article

References (23)

1. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003. 10.1097/01.CCM.0000226413.54364.36, 16715031.
2. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004, 32:2416-2421. 10.1097/01.CCM.0000147769.07699.E3, 15599145.
3. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38:S35-S42. 10.1097/CCM.0b013e3181c9e31d, 20083912.
4. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008, 106:1366-1375. 10.1213/ane.0b013e318168b367, 18420846.
5. Zacharowski K, Sucker C, Zacharowski P, Hartmann M. Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006, 95:557-561.
6. Velik-Salchner C, Streif W, Innerhofer P, Maier S, Knotzer H, Pajk W, Klingler A, Mittermayr M, Haas T. Endotoxinemia-induced changes in coagulation as measured by rotation thrombelastometry technique and conventional laboratory tests: results of a pilot study on pigs. Blood Coagul Fibrinolysis 2009, 20:41-46. 10.1097/MBC.0b013e32831be9ad, 19129727.
7. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM.: Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009, 13:R42. 10.1186/cc7765, 2689486, 19331653.
8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, . SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250. 2001, 10.1097/01.CCM.0000050454.01978.3B, 12682500, SCCM/ESICM/ACCP/ATS/SIS.
9. Le G, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957, 8254858.
10. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758. 10.1001/jama.286.14.1754, 11594901.
11. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96:644-647. 10.1111/j.1651-2227.2006.00178.x, 17376185.
12. Ebinger T, Ruland A, Lakner M, Schwaiger M. Validity, regulatory registration and approval of ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2010, 21:106-107. 10.1097/MBC.0b013e3283306e28, 20065662.
13. Gillies BS. Thromboelastography and liver transplantation. Semin Thromb Hemost 1995, 21(Suppl 4):45-49.
14. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA, . EACTS Audit and Guidelines Committee Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008, 34:73-92. 10.1016/j.ejcts.2008.02.024, 18375137, EACTS Audit and Guidelines Committee.
15. Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006, 10:R160. 10.1186/cc5098, 1794466, 17107615.
16. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-S34. 10.1097/CCM.0b013e3181c98d21, 20083910.
17. Boudjeltia KZ, Ollieuz S, Piagnerelli M, Biston P, Cauchie P, Vincent JL, Brohee D, Vanhaeverbeek M. Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand factor in critically ill patients. Thromb J 2009, 7:10.
18. van der Poll T, Levi M, Büller HR, van Deventer SJ, de Boer JP, Hack CE, ten Cate JW. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991, 174:729-732. 10.1084/jem.174.3.729, 2118940, 1714936.
19. Neyrinck AP, Liu KD, Howard JP, Matthay MA. Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol 2009, 158:1034-1047. 10.1111/j.1476-5381.2009.00251.x, 2785525, 19466992.
20. Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001, 85:5-11.
21. Savioli M, Cugno M, Polli F, Taccone P, Bellani G, Spanu P, Pesenti A, Iapichino G, Gattinoni L. Tight glycemic control may favor fibrinolysis in patients with sepsis. Crit Care Med 2009, 37:424-431. 10.1097/CCM.0b013e31819542da, 19114908.
22. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen-activator gene-function in mice. Nature 1994, 368:419-424. 10.1038/368419a0, 8133887.
23. Sun H, Wang X, Degen JL, Ginsburg D. Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 2009, 113:1358-1364. 10.1182/blood-2008-07-170506, 2637198, 19056689.